Viewing Study NCT04381468

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:35 PM
Ignite Modification Date: 2026-02-08 @ 11:01 AM
Study NCT ID: NCT04381468
Status: COMPLETED
Last Update Posted: 2024-08-22
First Post: 2020-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)
Sponsor: Vaccinex Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mild Cognitive Impairment View
None Mild Alzheimer's Dementia View
None Early Alzheimer's Disease View
None VX15/2503 View
None Semaphorin 4D View
None SEMA4D View
None monoclonal antibody View